ClinicalTrials.gov record
Recruiting Phase 1 Interventional

A Study to Learn About the Study Medicine Called Zavegepant (PF-07930207) in Children With a History of Migraine

ClinicalTrials.gov ID: NCT06995729

Public ClinicalTrials.gov record NCT06995729. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 18, 2026, 4:34 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A PHASE 1, MULTICENTER, OPEN-LABEL, SINGLE-DOSE STUDY TO EVALUATE THE SAFETY, TOLERABILITY AND PHARMACOKINETICS OF ZAVEGEPANT IN CHILDREN 6 TO LESS THAN 12 YEARS OF AGE WITH HISTORY OF MIGRAINE

Study identification

NCT ID
NCT06995729
Recruitment status
Recruiting
Study type
Interventional
Phase
Phase 1
Lead sponsor
Pfizer
Industry
Enrollment
16 participants

Conditions and interventions

Interventions

  • Zavegepant Drug

Drug

Eligibility (public fields only)

Age range
6 Years to 11 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
May 15, 2025
Primary completion
Aug 11, 2027
Completion
Aug 11, 2027
Last update posted
Mar 17, 2026

2025 – 2027

United States locations

U.S. sites
13
U.S. states
10
U.S. cities
11
Facility City State ZIP Site status
Arkansas Children's Hospital Little Rock Arkansas 72202 Not yet recruiting
Velocity Clinical Research, Washington DC Washington D.C. District of Columbia 20016 Not yet recruiting
Coastal Heritage Clinical Research Hinesville Georgia 31313 Recruiting
Clinical Research Institute Minneapolis Minnesota 55402 Not yet recruiting
Children's Hospital & Medical Center Omaha Nebraska 68114 Recruiting
True North Neurology Port Jefferson Station New York 11776 Not yet recruiting
Accellacare - Piedmont Statesville North Carolina 28625 Recruiting
Accellacare of Piedmont HealthCare Statesville North Carolina 28625 Recruiting
Accellacare US Inc. Winston-Salem North Carolina 27103 Recruiting
Central States Research Tulsa Oklahoma 74136 Recruiting
Cedar Health Research Dallas Texas 75251 Recruiting
Wasatch Clinical Research, LLC Salt Lake City Utah 84107 Recruiting
Granger Medical Holladay - Holladay Clinic Salt Lake City Utah 84117 Recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT06995729, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Mar 17, 2026 · Synced May 18, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT06995729 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →